{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:47:21Z","timestamp":1790624841108,"version":"4.1.0"},"reference-count":93,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Fibromyalgia is the most common of the central sensitivity syndromes affecting 2\u20135% of the adult population in the United States. This pain amplification syndrome has enormous societal impact as measured by work absenteeism, decreased work productivity, disability and injury compensation and over-utilization of healthcare resources. Multiple studies have shown that early diagnosis of this condition can improve patient outlook and redirect valuable healthcare resources towards more appropriate targeted therapy. Efforts have been made towards improving diagnostic accuracy through updated criteria. The search for biomarkers for diagnosis and verification of Fibromyalgia is an ongoing process. Inadequacies with current diagnostic criteria for this condition have fueled these efforts for identification of a reproducible marker that can verify this disease in a highly sensitive, specific and reproducible manner. This review focuses on areas of research for biomarkers in fibromyalgia and suggests that future efforts might benefit from approaches that utilize arrays of biomarkers to identify this disorder that presents with a diverse clinical phenotype.<\/jats:p>","DOI":"10.3390\/diagnostics11020156","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T11:49:40Z","timestamp":1611229780000},"page":"156","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["The Search for Biomarkers in Fibromyalgia"],"prefix":"10.3390","volume":"11","author":[{"given":"Kevin V.","family":"Hackshaw","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Dell Medical School at the University of Texas at Austin, 1601 Trinity St, Austin, TX 78712, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Biomarkers Definitions Working Group (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 69, 89\u201395.","DOI":"10.1067\/mcp.2001.113989"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00216-009-2690-3","article-title":"From differentiating metabolites to biomarkers","volume":"394","author":"Koulman","year":"2009","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.36076\/ppj.2011\/14\/E217","article-title":"Fibromyalgia: An afferent processing disorder leading to a complex pain generalized syndrome","volume":"14","author":"Smith","year":"2011","journal-title":"Pain Physician"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: A new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"Yunus","year":"2008","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1521-6942(03)00035-4","article-title":"Chronic widespread pain and fibromyalgia: What we know, and what we need to know","volume":"17","author":"Clauw","year":"2003","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2009.09.006","article-title":"Fibromyalgia: An overview","volume":"122","author":"Clauw","year":"2009","journal-title":"Am. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"c0157235","DOI":"10.1371\/journal.pone.0157235","article-title":"Three quarters of persons in the US population reporting a clinical diagnosis of fibromyalgia do not satisfy fibromyalgia criteria: The 2012 national health interview survey","volume":"11","author":"Wallit","year":"2016","journal-title":"PLoS ONE"},{"key":"ref_9","first-page":"534","article-title":"The fibromyalgia syndrome: A consensus report on fibromyalgia and disability","volume":"23","author":"Wolfe","year":"1996","journal-title":"J. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/JOM.0b013e31815cff4b","article-title":"Employees with fibromyalgia: Medical comorbidity, healthcare costs, and work loss","volume":"50","author":"White","year":"2008","journal-title":"J. Occup. Environ. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1185\/03007990902728456","article-title":"The economic burden of fibromyalgia: Comparative analysis with rheumatoid arthritis","volume":"25","author":"Silverman","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.23265","article-title":"Health economic consequences related to the diagnosis of fibromyalgia syndrome","volume":"58","author":"Annemans","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_13","first-page":"415","article-title":"The comparative economic burden of mild, moderate, and severe fibromyalgia: Results from a retrospective chart review and cross-sectional survey of working-age US adults","volume":"18","author":"Chandran","year":"2012","journal-title":"J. Manag. Care Pharm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s11934-007-0081-x","article-title":"Economic impact of chronic prostatitis","volume":"8","author":"Duloy","year":"2007","journal-title":"Curr. Urol. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.urology.2008.11.007","article-title":"Comparison of the economic impact of chronic prostatitis\/chronic pelvic pain syndrome and interstitial cystitis\/painful bladder syndrome","volume":"73","author":"Clemens","year":"2009","journal-title":"Urology"},{"key":"ref_16","first-page":"270","article-title":"Fibromyalgia versus rheumatoid arthritis: A longitudinal comparison of the quality of life","volume":"22","author":"Martinez","year":"1995","journal-title":"J. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/00005650-199609000-00005","article-title":"Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: Disability and health-care use","volume":"34","author":"Bombardier","year":"1996","journal-title":"Med. Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/11535250-000000000-00000","article-title":"Impact of fibromyalgia severity on health economic costs","volume":"9","author":"Winkelmann","year":"2011","journal-title":"Appl. Health Econ. Health Policy"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American college of rheumatology 1990 criteria for the classification of fibromyalgia","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3899\/jrheum.170095","article-title":"Comparative evaluation of the 2011 and 2016 criteria for fibromyalgia","volume":"44","author":"Ablin","year":"2017","journal-title":"J. Rheum."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/pm\/pnx155","article-title":"The accuracy of a fibromyalgia diagnosis in general practice","volume":"19","author":"Gittins","year":"2018","journal-title":"Pain Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/pm\/pnx271","article-title":"A Survey of physicians\u2019 knowledge and adherence to the diagnostic criteria for fibromyalgia","volume":"19","author":"Kumbhare","year":"2018","journal-title":"Pain Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00482-012-1169-x","article-title":"Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis","volume":"26","author":"Eich","year":"2012","journal-title":"Schmerz"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"528952","DOI":"10.1155\/2013\/528952","article-title":"Classification and clinical diagnosis of fibromyalgia syndrome: Recommendations of recent evidence-based interdisciplinary guidelines","volume":"2013","author":"Fitzcharles","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/918216","article-title":"2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: Executive summary","volume":"18","author":"Fitzcharles","year":"2013","journal-title":"Pain Res. Manag."},{"key":"ref_27","first-page":"232","article-title":"Methodological fundamentals of the development of the guideline","volume":"26","author":"Hauser","year":"2012","journal-title":"Schmerz"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1080\/14737159.2020.1858054","article-title":"Assessing our approach to diagnosing fibromyalgia","volume":"20","author":"Hackshaw","year":"2020","journal-title":"Exp. Rev. Mol. Diag."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.10225","article-title":"Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia","volume":"46","author":"Gracely","year":"2002","journal-title":"Arthritis Rheum."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0753-3322(00)89044-7","article-title":"Individual reactivity and physiology of the stress response","volume":"54","author":"Negrao","year":"2000","journal-title":"Biomed. Pharmacother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2217\/17460816.3.5.475","article-title":"Heart rate variability as a biomarker of fibromyalgia syndrome","volume":"3","author":"Staud","year":"2008","journal-title":"Fut. Rheumat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/art.20042","article-title":"Family study of fibromyalgia","volume":"50","author":"Arnold","year":"2004","journal-title":"Arthritis Rheum."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0049-0172(96)80011-4","article-title":"Familial aggregation in the fibromyalgia syndrome","volume":"26","author":"Buskila","year":"1996","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1001\/archinte.166.15.1649","article-title":"Chronic widespread pain and its comorbidities: A population-based study","volume":"166","author":"Kato","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1017\/S0033291708003784","article-title":"A population-based twin study of functional somatic syndromes","volume":"39","author":"Kato","year":"2008","journal-title":"Psychol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1146\/annurev.neuro.23.1.777","article-title":"Pain genes? Natural variation and transgenic mutants","volume":"23","author":"Mogil","year":"2000","journal-title":"Ann. Rev. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/hmg\/ddi013","article-title":"Genetic basis for individual variations in pain perception and the development of a chronic pain condition","volume":"14","author":"Diatchenko","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pain.2006.05.024","article-title":"Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain evoking stimuli","volume":"125","author":"Diatchenko","year":"2006","journal-title":"Pain"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.mp.4001568","article-title":"An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits","volume":"9","author":"Buskila","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3904\/kjim.2016.207","article-title":"New insights into the genetics of fibromyalgia","volume":"32","author":"Park","year":"2017","journal-title":"Korean J. Intern. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3470001","article-title":"Tetrahydrobiopterin biosynthesis, regeneration and functions","volume":"347","author":"Thony","year":"2000","journal-title":"Biochem. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3899\/jrheum.120929","article-title":"Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population","volume":"40","author":"Kim","year":"2013","journal-title":"J. Rheumatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1526-4637.2011.01179.x","article-title":"MCP-1 and IL-8 as pain biomarkers in fibromyalgia: A pilot study","volume":"8","author":"Ang","year":"2011","journal-title":"Pain Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10067-010-1474-7","article-title":"Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients","volume":"29","author":"Blanco","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/03009749709105321","article-title":"Dermal IgG deposits and increase of mast cells in patients with fibromyalgia\u2014relevant findings or epiphenomena?","volume":"26","author":"Enestrom","year":"1997","journal-title":"Scand. J. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/sj.npp.1301200","article-title":"Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia","volume":"31","author":"Mclean","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1749-6632.2002.tb04251.x","article-title":"Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: Role of somatostatin and CRH-binding protein","volume":"966","author":"Riedel","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3959(88)90019-X","article-title":"Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: New features for diagnosis","volume":"32","author":"Vaeroy","year":"1988","journal-title":"Pain"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/art.1780371106","article-title":"Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome","volume":"37","author":"Russell","year":"1994","journal-title":"Arthritis Rheum."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10067-009-1094-2","article-title":"Evaluating obesity in fibromyalgia: Neuroendocrine biomarkers, symptoms and functions","volume":"4","author":"Okifuji","year":"2009","journal-title":"Clin. Rheum."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0002-9343(01)01089-0","article-title":"A randomized placebo-controlled, double-blind, flexible -dose study of fluoxetine in the treatment of women with fibromyalgia","volume":"112","author":"Arnold","year":"2002","journal-title":"Am. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/ard.56.4.268","article-title":"The relation between tender points and fibromyalgia symptom variables: Evidence that fibromyalgia is not a discrete disorder in the clinic","volume":"56","author":"Wolfe","year":"1997","journal-title":"Ann. Rheum. Dis."},{"key":"ref_53","first-page":"567","article-title":"What do tender points measure? Influence of distress on 4 measures of tenderness","volume":"30","author":"Petzke","year":"2003","journal-title":"J. Rheumatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpain.2006.01.455","article-title":"Comparison of clinical and evoked pain measures in fibromyalgia","volume":"77","author":"Harris","year":"2006","journal-title":"J. Pain"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0304-3959(03)00204-5","article-title":"Increased pain sensitivity in fibromyalgia: Effects of stimulus type and mode of presentation","volume":"105","author":"Petzke","year":"2003","journal-title":"Pain"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3959(96)03295-2","article-title":"Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects","volume":"70","author":"Kosek","year":"1997","journal-title":"Pain"},{"key":"ref_57","first-page":"1925","article-title":"Abnormal responses to electrocutaneous stimulation in fibromyalgia","volume":"201","author":"Arroyo","year":"1993","journal-title":"J. Rheumatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00006842-197507000-00008","article-title":"Musculoskeletal symptoms and non-REM sleep disturbance in patients with \u201cfibrositis syndrome\u201d and healthy subjects","volume":"37","author":"Moldofsky","year":"1975","journal-title":"Psychosom. Med."},{"key":"ref_59","first-page":"1113","article-title":"Sleep cycles and alpha-delta sleep in fibromyalgia syndrome","volume":"21","author":"Branco","year":"1994","journal-title":"J. Rheumatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1001\/archinte.165.21.2527","article-title":"Behavioral insomnia therapy for fibromyalgia patients: A randomized clinical trial","volume":"165","author":"Edinger","year":"2005","journal-title":"Arch. Int. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbi.2003.12.011","article-title":"Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and\/or chronic fatigue syndrome","volume":"18","author":"Crofford","year":"2004","journal-title":"Brain Behav. Immun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0306-4530(92)90017-2","article-title":"Clinical relevance of antibodies against serotonin and gangliosides in patients with primary fibromyalgia syndrome","volume":"17","author":"Klein","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"ref_63","first-page":"595","article-title":"Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome","volume":"28","author":"Werle","year":"2001","journal-title":"J. Rheumatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00000441-199806000-00006","article-title":"Advances in fibromyalgia: Possible role for central neurochemicals","volume":"315","author":"Russell","year":"1998","journal-title":"Am. J. Med. Sci."},{"key":"ref_65","first-page":"73","article-title":"An analysis of antibodies to serotonin receptors in fibromyalgia","volume":"3","author":"Vedderci","year":"1995","journal-title":"J. Musculoskelet. Pain"},{"key":"ref_66","first-page":"1564","article-title":"Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia","volume":"26","author":"Giovengo","year":"1999","journal-title":"J. Rheum."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jpain.2007.05.002","article-title":"Increased levels of neurotrophins are not specific for chronic migraine: Evidence from primary fibromyalgia syndrome","volume":"8","author":"Sarchielli","year":"2007","journal-title":"J. Pain"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jpsychires.2006.02.007","article-title":"Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants","volume":"41","author":"Laske","year":"2007","journal-title":"J. Psyc. Res."},{"key":"ref_69","first-page":"90","article-title":"Plasma tryptophan and other amino acids in primary fibromyalgia: A controlled study","volume":"19","author":"Yunus","year":"1992","journal-title":"J. Rheumatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"13667","DOI":"10.1038\/s41598-019-49403-7","article-title":"No evidence for altered plasma NGF and BDNF levels in fibromyalgia patients","volume":"9","author":"Baumeister","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2340\/16501977-2593","article-title":"Unaltered low nerve growth factor and high brain-derived neurotrophic factor levels in plasma from patients with fibromyalgia after a 15-week progressive resistance exercise","volume":"51","author":"Jablochkova","year":"2019","journal-title":"J. Rehab. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2265.1998.00503.x","article-title":"Fibromyalgia\u2014A syndrome associated with decreased nocturnal melatonin secretion","volume":"49","author":"Wikner","year":"1998","journal-title":"Clin. Endocrinol."},{"key":"ref_73","first-page":"351","article-title":"Skeletal muscle abnormalities in patients with fibromyalgia","volume":"315","author":"Olsen","year":"1998","journal-title":"Amer. J. Med. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(86)91779-4","article-title":"Histological abnormalities in muscle from patients with certain types of fibrositis","volume":"1","author":"Bartels","year":"1986","journal-title":"Lancet"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/rheumatology\/32.6.479","article-title":"Pathology of skeletal muscle in fibromyalgia: A histoimmunochemical and ultrastructural study","volume":"32","author":"Drewes","year":"1993","journal-title":"Br. J. Rheumatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.1780290701","article-title":"Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia","volume":"29","author":"Bengtsson","year":"1986","journal-title":"Arthritis Rheum."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/03009749509095152","article-title":"Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls","volume":"24","author":"Lindh","year":"1995","journal-title":"Scand. J. Rheumatol."},{"key":"ref_78","first-page":"144","article-title":"The muscle in fibromyalgia: A review of Swedish studies","volume":"16","author":"Bengtsson","year":"1989","journal-title":"J. Rheumatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.pain.2013.06.001","article-title":"Objective evidence that small fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia","volume":"154","author":"Oaklander","year":"2013","journal-title":"Pain"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4172\/2329-6895.1000305","article-title":"Small fiber neuropathy in patients meeting diagnostic criteria for fibromyalgia","volume":"4","author":"Levine","year":"2016","journal-title":"J. Neurol. Disord."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/mus.26131","article-title":"Fibromyalgia syndrome and small fiber, early or mild sensory polyneuropathy","volume":"23","author":"Lawson","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00296-014-3172-2","article-title":"Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: A potentially useful tool in differential diagnosis","volume":"35","author":"Wallace","year":"2015","journal-title":"Rheum. Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1039\/c3an36615d","article-title":"A bloodspot-based diagnostic test for fibromyalgia syndrome and related disorders","volume":"138","author":"Hackshaw","year":"2013","journal-title":"Analyst"},{"key":"ref_84","unstructured":"Diem, M., Griffiths, P.R., and Chalmers, J.M. (2008). Vibrational Spectroscopy for Medical Diagnosis, Wiley."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1039\/b822130h","article-title":"Vibrational spectroscopy: A clinical tool for cancer diagnostics","volume":"134","author":"Kendall","year":"2009","journal-title":"Analyst"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1387-2656(05)11006-0","article-title":"Vibrational spectroscopy for molecular characterization and diagnosis of benign, premalignant and malignant skin tumours","volume":"11","author":"Eikje","year":"2005","journal-title":"Biotechnol. Annu. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Hackshaw, K.V., Miller, J.S., Aykas, D.P., and Rodriguez-Saona, L. (2020). Vibrational spectroscopy for identification of metabolites in biologic samples. Molecules, 25.","DOI":"10.3390\/molecules25204725"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Miller, J.S., Rodriguez-Saona, L., and Hackshaw, K.V. (2020). Metabolomics in central sensitivity syndromes. Metabolites, 10.","DOI":"10.3390\/metabo10040164"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12883-017-0863-9","article-title":"A diagnostic biomarker profile for fibromyalgia syndrome based on an NMR metabolomics study of selected patients and controls","volume":"17","author":"Malatji","year":"2017","journal-title":"BMC Neurol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1074\/jbc.RA118.005816","article-title":"Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders","volume":"294","author":"Hackshaw","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1038\/s41598-020-68781-x","article-title":"Spectrochemical analysis in blood plasma combined with subsequent chemometrics for fibromyalgia detection","volume":"10","author":"Morais","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.foodchem.2014.11.001","article-title":"Application of handheld and portable spectrometers for screening acrylamide content in commercial potato chips","volume":"174","author":"Ayvaz","year":"2015","journal-title":"Food Chem."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Raffaeli, W., Malafoglia, V., Bonci, A., Tenti, M., Ilari, S., Gremigni, P., Iannuccelli, C., Gioia, C., Di Franco, M., and Mollace, V. (2020). Identification of MOR-positive B cell as possible innovative biomarker (mu lympho-marker) for chronic pain diagnosis in patients with fibromyalgia and osteoarthritis diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041499"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/11\/2\/156\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:13:43Z","timestamp":1760159623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/11\/2\/156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":93,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["diagnostics11020156"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics11020156","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]}}}